-
Some Criteria To Determine A New Drug’s Potential For Causing Severe Drug-Induced Liver Injury (DILI)
In July 2009 FDA Issues Updated Guidance For Industry Document Concerning DILI In Premarketing Clinical Evaluation (Posted by Tom Lamb at DrugInjuryWatch.com) In July 2009 the FDA issued a Guidance for Industry document intended for pharmaceutical…
-
Diabetes Drug Avandia Associated With Liver Injury And Liver Failure, Again
July 2009 Medical Journal Article Follows 2008 Public Citizen's Petition For FDA To Ban Sales Of Avandia In U.S. (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2008 Public Citizen petitioned the FDA to…
-
Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed Late July 2009
Requests Consolidation Of Federal Court Lawsuits Alleging Yasmin Or YAZ Caused Injury Such As Stroke, Heart Attack, Pulmonary Thrombosis, Deep Vein Thrombosis, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ Update: On October 1,…
-
A Summary Of Inpatient Cardiovascular Medication Error Reports Involving Children
July 2009 Pediatrics Medical Journal Article Finds Most Cases Involved Infants Less Than One Year Of Age (Posted by Tom Lamb at DrugInjuryWatch.com) The article "Cardiovascular Medication Errors in Children" was published in the July…
-
July 2009 Medical Journal Article Suggests That Zelnorm May Not Cause Heart Attacks And Strokes
FDA And Health Canada Had Zelnorm Removed From Respective Markets In March 2007 Due To Concerns About Cardiovascular Safety (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2008 a national class action was filed…
